Clinical Physiology of Circulation

Chief Editor

Leo A. Bockeria, MD, PhD, DSc, Professor, Academician of Russian Academy of Sciences, President of Bakoulev National Medical Research Center for Cardiovascular Surgery


Ventilator-associated pneumonia in the cardiac intensive care unit

Authors: Lobacheva G.V., Popov D.A., Rakhimov A.A., Kolesnikova E.A.

Company:
A.N. Bakoulev Scientific Center for Cardiovascular Surgery, Rublevskoe shosse, 135, Moscow, 121552, Russian Federation

Link: Clinical Physiology of Blood Circulaiton. 2014; (): -

Quote as: Lobacheva G.V., Popov D.A., Rakhimov A.A., Kolesnikova E.A. Ventilator-associated pneumonia in the cardiac intensive care unit. Klinicheskaya Fiziologiya Krovoobrashcheniya. 2014; 3: 71-75.

Full text:  

Abstract

The analysis of published data on the treatment strategy of patients with ventilator-associated pneumonia in intensive care unit. Recommended range of preventive and therapeutic interventions that reduce the frequency of ventilator-associated pneumonia. It is shown that effective treatment is necessary to make the most rapid appointment of adequate antibiotic therapy, and conduct microbiological monitoring. In order to reduce the systemic toxic effects of antibiotic treatment with inhaled antibiotics proposed which allow to ensure the delivery of sufficient quantities of the preparation in infectious focus. Held stratification of risk factors ventilator-associated pneumonia in patients undergoing cardiac surgery.

References

1. Vincent J.L., Rello J., Marshall J., Silva E., Anzueto A., Martin C.D. et al. EPIC II Group of Investigators. JAMA. 2009; 302 (21): 2323–9.
2. Hortal J., Giannella M., Pérez M.J., Barrio J.M., Desco M., Bouza E., Mun~oz P. Incidence and risk factors for ventilator- associated pneumonia after major heart surgery. Intensive Care Med. 2009; 35(9): 1518–25.
3. Tejerina E., Frutos-Vivar F., Restrepo M.I., Anzueto A., Abroug F., Palizas F. et al. Internacional Mechanical Ventilation Study Group. Incidence, risk factors, and outcome of ventilator-associated pneumonia. J. Crit. Care. 2006; 21: 56–65.
4. Gatt M., Reddy B.S., MacFie J. Review article: bacterial translocation in the critically ill – evidence and methods of prevention. Aliment. Pharmacol. Ther. 2007; 25 (7): 741–57.
5. Koenig S.M., Truwit J.D. Ventilator-associated pneumonia: diagnosis, treatment, and prevention. Clin. Microbiol. Rev. 2006; 19 (4): 637–57.
6. Levy J.H., Tanaka K.A., Steiner M.E. Evaluation and man- agement of bleeding during cardiac surgery. Curr. Hematol. Rep. 2005; 4 (5): 368–72.
7. American Thoracic Society. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am. J. Respir. Crit. Care Med. 2005; 171: 388–416.
8. Butler K.L., Sinclair K.E., Henderson V.J., McKinney G., Mesidor D.A., Katon-Benitez I., Weaver W.L. The chest radi- ograph in critically ill surgical patients is inaccurate in predict- ing ventilator-associated pneumonia. Am. Surg. 1999; 65: 805–10.
9. Conway Morris A., Kefala K., Wilkinson T.S., Moncayo-Nie- to O.L., Dhaliwal K., Farrell L. et al. Diagnostic importance of pulmonary interleukin-1{beta} and interleukin-8 in ventilator- associated pneumonia. Thorax. 2010; 65 (3): 201–7.
10. Белобородова Н.В., Попов Д.А., Бачинская Е.Н. После- операционные инфекции в кардиохирургии: современ- ное состояние проблемы и перспективы. Грудная и сердеч- но-сосудистая хирургия. 2004; 4: 54–9.
11. Gastmeier P., Sohr D., Geffers C., Rüden H., Vonberg R.P., Welte T. Early- and late-onset pneumonia: is this still a useful classification? Antimicrob. Agents Chemother. 2009; 53 (7): 2714–8.
12. Giantsou E., Liratzopoulos N., Efraimidou E., Panopoulou M., Alepopoulou E., Kartali-Ktenidou S. et al. Both early-onset and late-onset ventilator-associated pneumonia are caused mainly by potentially multiresistant bacteria. Intensive Care Med. 2005; 31 (11): 1488–94.
13. Lee S.Y., Lee J.W., Jeong D.C., Chung S.Y., Chung D.S., Kang J.H. Multidrug-resistant Acinetobacter meningitis in a 3-year-old boy treated with i.v. colistin. Pediatr. Int. 2008; 50 (4): 584–5.
14. Rosanova M., Epelbaum C., Noman A., Villasboas M., Alvarez V., Berberian G. et al. Use of colistin in a pediatric burn unit in Argentina. J. Burn. Care Res. 2009; 30 (4): 612–5.
15. Giamarellos-Bourboulis E.J., Peche`re J.C., Routsi C., Plachouras D., Kollias S., Raftogiannis M. et al. Effect of clar- ithromycin in patients with sepsis and ventilator-associated pneumonia. Clin. Infect. Dis. 2008; 46 (8): 1157–64.
16. Leal-Noval S.R., Marquez-Vacaro J.A., Garcia-Curiel A., Camacho-Larana P., Rincon-Ferrari M.D., Ordonez- Fernandez A. et al. Nosocomial pneumonia in patients under- going heart surgery. Crit. Care Med. 2000; 28 (4): 935–40.
17. Pineda L.A., Saliba R.G., El Solh A.A. Effect of oral deconta- mination with chlorhexidine on the incidence of nosocomial pneumonia: a meta-analysis. Crit. Care. 2006; 10 (1): R35.

 If you found mistakes, select text and press Alt+A